Assessment of the antiexudative and antiproliferative activities of non-steroidal anti-inflammatory drugs in inflammatory models developed in rats by subcutaneous implantation of bacterial cell walls from the dental plaque

Inflammation

Volumn 20, Issue 6, 1996, Pages 623-636

  Catanzaro Guimarães, Sérgio A ^a   Akatsu, Tadashi ^b   Tago, Eulázio M ^a   Consolaro, Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAMETACIN; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CELL SUSPENSION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG POTENCY; DUODENUM MUCOSA; EXUDATE; GRANULOMA; INFLAMMATION; INTRAGASTRIC DRUG ADMINISTRATION; MALE; MITOSIS; NONHUMAN; RAT; TOOTH PLAQUE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPILLARY PERMEABILITY; CELL DIVISION; CELL WALL; CHILD; DENTAL PLAQUE; DNA REPLICATION; DUODENUM; EDEMA; EXUDATES AND TRANSUDATES; GRANULOMA; GROWTH INHIBITORS; HUMANS; IBUPROFEN; INDOMETHACIN; INFLAMMATION; INTESTINAL MUCOSA; NAPROXEN; RATS; SULINDAC;

EID: 1542425751     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01488800     Document Type: Article

References (38)

1. ZWEIFACH, B. W. 1965. Microvascular aspects of tissue injury. In The Inflammatory Process. Zweifach, B. W., L. Grant, and R. T. Cluskey, editors. Academic Press, New York. Vol. I, pp. 161-196.
2. SPECTOR, W. G. 1975. Cellular events in inflammation. In Inflammation and Antiinflammatory Therapy, G. Katona, and J. R. Blengio, editors. Spectrum, New York, pp. 153-156.
3. CATANZARO GUIMARÃES, S. A. 1982. In Patologia Básica da Cavidade Bucal. Guanabara Koogan, Rio de Janeiro, pp. 197-220.
4. COTRAN, R. S., KUMAR, V. and ROBBINS, S. L. 1989. In Robbins Pathologic Basis of Disease. W. B. Saunders Co., Philadelphia, 4th ed., pp. 39-86.
5. RUBIN, E. L. and FARBER, J.L. 1994. In Pathology, J. B. Lippincott, Philadelphia, 2nd ed., pp. 34-66.
6. PAULUS, H. E. 1974. Some inflammatory diseases in man and their current therapy. In Antiinflammatory Agents. Chemistry and Pharmacology. R. A. Scherrer, and M. W. Whitehouse, editors. Academic Press, London, Vol. 1, pp. 3-26.
7. CHAHADE, W. H. 1978. A inflamação e os antiinflamatórios não hormonais. Rev. Bras. Clin. Ter. 7:683-693.
8. VANE, J. R. 1978. The mode of action of aspirin-like drugs. Agents Actions 8:430-431.
9. FLOWER, R. J., S. MONCADA, and J. R. VANE. 1980. Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In The Pharmacological Basis of Therapeutics. L. S. Goodman, and A. Gilman, editors. MacMillan, New York, 6th ed., pp. 682-728.
10. MENEZES, M. R. D. and S. A. CATANZARO GUIMARÃES, 1985. Determination of anti-inflammatory and antimitotic activities of non-steroid anti-inflammatory drugs ibuprofen, diclofenac sodium and fentiazac. Cell. Mol. Biol. 31:455-461.
11. AKATSU, T. and S. A. CATANZARO GUIMARÃES. 1986. Comparative effects of non-steroidal anti-inflammatory drugs, mefenamic acid, metiazinic acid and glucametacin on the inflammatory response induced by subcutaneous implantation of human dental plaque and on the mitotic activity of isoproterenol-stimulated parotid glands of rats. Cell. Mol. Biol. 32:619-626.
12. WALLINDER, I. and H. Y. NEUJAHR. 1971. Cell wall peptidoglycan from Lactobacillus fermenti. J. Bact. 105:918-926.
13. HARTREE, E. F. 1972. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Analyt. Biochem. 48:422-427.
14. DUBOIS, M., K. A. GILLES, J. K. HAMILTON, P. A. REBERS, and F. SMITH. 1956. Colorimetric method for determination of sugars and related substances. Analyt. Chem. 28:350-356.
15. WILHELM, D. L. and B. MASON. 1960. Vascular permeability changes in inflammation: the role of endogenous permeability factors in mild thermal injury. Brit. J. Exp. Path. 41:487-506.
16. MOVAT, H. Z., N. L. DILORENZO, and N. S. TAICHMAN. 1967. Supression by antihistamine of passive cutaneous anaphylaxis produced with anaphylactic antibody in the guinea-pig. J. Immunol. 98:230-235.
17. UDAKA, K., Y. TAKEUCHI, and H. Z. MOVAT. 1970. Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. (N.Y.) 133:1384-1387.
18. SWINGLE, K. F. and F. E. SHIDEMAN. 1972. Phases of inflammatory responses to sub-cutaneous implantation of a cotton pellet and their modification by certain anti-inflammatory agents. J. Pharmacol. Exp. Ther. 183:226-234.
19. AHERNE, W. 1967. Methods of counting discrete tissue components in microscopical sections. J. Roy. Micr. Soc. 87:493-508.
20. CHALKLEY, H. W. 1943. A method for quantitative morphologic analysis of tissue. J. Nat. Cancer Inst. 4:47-53.
21. CATANZARO GUIMARÃES, S. A. 1968. Histometric determination of collagen fibers in granulating wounds of alloxan diabetic rats. Experientia (Basel) 24:1168-1169.
22. SCOTT, J. F., A. P. FRACCASTORO, and E. B. TAFT. 1956. Studies on histochemistry. I. Determination of nucleic acids in microgram amounts of tissue. J. Histochem. Cytochem. 4:1-10.
23. CATANZARO GUIMARÃES, S. A. and R. BASERGA. 1973. Effect of urethane on isoproterenol-stimulated parotid glands of mice. Lab. Invest. 29:367-373.
24. SWINGLE, K. F. 1974. Evaluation for antiinflammatory activity. In Anti-inflammatory Agents. Chemistry and Pharmacology. R. A. Scherrer, and M. W. Whitehouse, editors. Academic Press, London, Vol. 2, pp. 33-109.
25. TAICHMAN, N. S., H. L. FREEDMAN, and T. URIUHARA. 1966. Inflammation and tissue injury. I - The response to intradermal injections of human dento-gingival plaque in normal and leukopenic rabbits. Archs. Oral Biol. 11:1385-1392.
26. VINEGAR, R., W. SCHREIBER, and R. HUGO. 1969. Biphasic development of carrageenin edema in rats. J. Pharmacol. Exp. Ther. 166:96-103.
27. VANE, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (Lond.) 231:232-235.
28. SMITH, J. B. and A. L. WILLIS. 1971. Aspirin selectively inhibits prostaglandin production in human platelets. Nature (Lond.) 231:235-237.
29. FERREIRA, S. H., S. MONCADA, and J. R. VANE. 1971. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature (Lond.) 231:237-239.
30. FLOWER, R. J., R. GRYGLEWSKI, and K. HERBACZÝNSKA-CEDRO. 1972. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature (Lond.) 238:104-106.
31. FERREIRA, S. H. and J. R. VANE. 1973. New aspects of the mode of action of nonsteroid antiinflammatory drugs. Ann. Rev. Pharmacol. 14:57-71.
32. FLOWER, R. J. 1974. Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev. 26:37-67.
33. VANE, J. R., and R. M. BOTTING. 1990. The mode of action of anti-inflammatory drugs. Postgrad. Med. J. 66 (Suppl. 4): S2-S17.
34. BRETTSCHNEIDER, I., R. PRAUS, and J. MUSILOVÁ. 1976. Effect of some anti-rheumatics on connective tissue components. Arzneimittel-Forsch. 26:846-848.
35. TRNAVSKÝ, K. 1974. Some effects of antiinflammatory drugs on connective tissue metabolism. In Anti-inflammatory Agents. Chemistry and Pharmacology. R. A. Scherrer, and M. W. Whitehouse, editors. Academic Press, London, Vol. 2, pp. 303-324.
36. PALKA, J., and Z. GALEWSKA. 1990. The effect of some antiinflammatory drugs on collagen of rat skin. Pol. J. Pharmacol. 42:39-42.
37. BASERGA, R. 1968. Biochemistry of the cell cycle. A review. Cell. Tiss. Kinet. 1:167-191.
38. BASERGA, R. 1969. In Biochemistry of Cell Division. Charles C. Thomas Publ., Springfield, pp. 3-13.